News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Agios Pharmaceuticals, Inc.
NEWS
JOBS
IN THE PRESS
AWARDS
NEWS
Biotech Bay
Top 5 Biotech Stocks to Buy for 2018
A new RBC report is reasonably positive on the biotech sector for 2018 and here are some reasons why.
December 21, 2017
·
2 min read
·
Mark Terry
FDA
Agios, Celgene Win Early FDA Approval for New Cancer Drug
August 1, 2017
·
2 min read
Drug Development
Cambridge Biotech Agios Terminates AG-519 for PK Deficiency, But Continues AG-348 For Same Condition
December 16, 2016
·
2 min read
FDA
Another Celgene Bet Pays Off as Agios Eyes Early Approval of Leukemia Drug
September 7, 2016
·
2 min read
Business
Former BIND Therapeutics CEO Joins Agios as New CFO
August 16, 2016
·
2 min read
Business
Agios, Celgene Hammer Out $1 Billion+ Metabolic Immuno-Oncology Deal
May 18, 2016
·
3 min read
Genetown
10 Massachusetts Biotechs Devoting the Most Cash to R&D
May 5, 2016
·
3 min read
Genetown
Celgene And Agios Deliver Some Great “Bad” News
June 18, 2015
·
1 min read
Business
Celgene Dealmaking Continues With Two Pacts Worth $110 Million With Agios, Northern Biologics
April 29, 2015
·
3 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia
May 24, 2026
·
5 min read
Press Releases
Agios’ PYRUKYND® (mitapivat) Approved in the European Union for Adults with Thalassemia
May 24, 2026
·
15 min read
Press Releases
Agios to Present New Data at EHA 2026 Reinforcing the Significant Therapeutic Impact of Mitapivat Across Multiple Rare Hemolytic Anemias
May 12, 2026
·
21 min read
Press Releases
Agios Submits sNDA to FDA for U.S. Accelerated Approval of Mitapivat in Sickle Cell Disease
May 12, 2026
·
10 min read
Press Releases
Agios Reports First Quarter 2026 Financial Results and Provides Business Update
April 29, 2026
·
11 min read
Press Releases
Agios to Host First Quarter 2026 Financial Results Conference Call and Webcast on April 29 at 8:00 a.m. ET
April 6, 2026
·
2 min read
Press Releases
Agios Advances Mitapivat Toward Potential U.S. Accelerated Approval in Sickle Cell Disease Following Pre-sNDA Meeting with FDA
March 31, 2026
·
8 min read
Press Releases
Agios’ PYRUKYND® (mitapivat) Approved for Adults with Thalassemia in the United Arab Emirates
March 2, 2026
·
14 min read
Press Releases
Agios Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
February 12, 2026
·
10 min read
Press Releases
Agios to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call and Webcast on February 12 at 8:00 a.m. ET
January 27, 2026
·
1 min read
